The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for ...

DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food and Drug Administration for a new glucose monitoring system. Shares of the ...

Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...

DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...

The role of Continuous Glucose Monitoring (CGM) system like Dexcom G7 in Nick's diabetes journey Nick’s message also highlighted the Dexcom G7, a continuous glucose monitoring (CGM) system that ...

Personal continuous glucose monitors are accurate at measuring glucose levels in most ranges for hospitalized patients with ...

According to Yogish C. Kudva, Division of Endocrinology, Diabetes, Nutrition, Mayo Clinic, Rochester, Minnesota, USA, and ...

The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...

All Dexcom U athletes rely on Dexcom continuous glucose monitoring technology, like Dexcom G7, to manage their diabetes with real-time glucose data delivered to their smartphone or smartwatch ...

In addition to improved accuracy, the Dexcom G7 15 Day allows for 15.5 days of wear. The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM ...